vinpocetine has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dzizinskiĭ, AA; Filatova, LN; Kuklin, SG; Protasov, KV; Shprakh, VV; Sinkevich, DA | 1 |
| Bondarenko, IP | 1 |
2 other study(ies) available for vinpocetine and Coronary Disease
| Article | Year |
|---|---|
[Cavinton forte treatment of cerebral vascular insufficiency in patients with coronary heart disease and arterial hypertension].
Topics: Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Disorders; Coronary Disease; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Neuroprotective Agents; Treatment Outcome; Vinca Alkaloids | 2006 |
[Correction of hemodynamic and metabolic disorders in patients with ischemic heart disease].
Topics: Aged; Aged, 80 and over; Anabolic Agents; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Estrenes; Hemodynamics; Humans; Middle Aged; Trimethylsilyl Compounds; Vasodilator Agents; Vinca Alkaloids | 1988 |